Pancreatic Cancer Research

ResearcherInsermNo recent work listed

David Taïeb

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0400-7600; OpenAlex author ID A5013015930. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 trial

Papers 1

  1. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer. Co-author DOI 10.1038/cddis.2011.104↗

Trials 1

  1. Evaluation of PET-CT Using Somatostatin Agonists Labeled With Gallium68 in Neuroendocrine Tumors Principal investigator NCT02150408↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Palma Rocchi · 1 shared paper, 2011 · strength 0.02
  2. Virginie Baylot · 1 shared paper, 2011 · strength 0.02
  3. Juan Iovanna · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.